Current committee members include:
Oliver Tattan, Chair, ARCH Centre Steering Committee
Eamonn Fitzgerald, ARCH Centre Steering Committee
Since joining the Hermitage Medical Clinic, Eamonn oversaw the accreditation of the hospital by the Joint Commission International (JCI) in 2008. The hospital is fully committed to the development and maintenance of international best practice and standards in the governance and oversight of clinical care. Its strategic vision revolves around an institutional commitment to interagency corporation and collaboration in the areas of clinical service delivery, education and research.
Eamonn has worked in Healthcare and Social Services for the past 25-years. Prior to moving in 2006 to start up the Hermitage Clinic, he held the position of Deputy Chief Executive of St. Vincent’s Healthcare Group for ten years. During his time at SVHG Eamonn contributed to collaborative efforts in the forging of relationships between the Dublin Molecular Medicine Centre (DMMC), University College Dublin (UCD) and participated in multiple grant applications (PRTLI and others). He worked as an Allied Health Professional for seven years in Beaumont Hospital before joining St Vincent’s Healthcare Group.
In the past Eamonn has worked as a consultant to the International Unit of the Institute of Public Administration delivering consulting programmes in a variety of DGs (Directorates General /EU Administrations) in the European Commission as well as overseas work in South Africa. He was chair of the State Claims Agency’s Clinical Indemnity Scheme, ICT Procurement and Implementation Steering Groups for the design, acquisition and roll‐out of the Stars‐Web Enterprise Liability, Clinical Claims and Risk Management Software Application(s). He is a Board Member of the Dublin Clinical Centres for Research (DCCR) and an industry board member of Enterprise Ireland’s / UCD / Connected Health Steering Group. In addition to the forgoing, Eamonn sits on the Board of i360 Medical, a healthcare solutions and medical device innovation company that takes new healthcare ideas and medical technologies to market. More recently Eamonn has joined the board of Health XL which is a global clearing house for innovation in healthcare.
Eamonn has a Master’s Degree in Business Studies specialising in Management and Organisational Systems from the Michael Smurfit Graduate School, UCD and a Master of Science in Economics from Trinity College, Dublin. He is a graduate of University College Cork (UCC) in Social Studies and Social Work.
Jim O'Donoghue, Vice President Connected Health S3 Group
Jim passionately believes that Connected Health will fundamentally change the way healthcare is delivered and experienced by patients and clinicians. Over the past 10 years Jim has assembled a world-class team that have delivered award winning solutions in Remote Patient Monitoring, Medication Adherence and Chronic Disease Management for clients throughout Europe, North America and Australasia.
Jim is a regular speaker at industry conferences and has been centrally involved in a number of key industry and health system initiatives in Ireland and the UK.
Godfrey Fletcher, CEO, Vu2Vu
Prof Orla Feely, Vice President for Research, Innovation and Impact, UCD
Professor Feely was previously Chair of the Irish Research Council. A Fellow of the IEEE (Institute of Electrical and Electronics Engineers) and former Chair of the IEEE Technical Committee on Nonlinear Circuits and Systems, Professor Feely is also a Fellow of Engineers Ireland and the Irish Academy of Engineering. She is a director of the Young Scientist and Technology Exhibition and a member of the EU Horizon 2020 Advisory Group on Marie Sklodowska-Curie Actions.
Leo Kearns, National Lead for Transformation and Change, HSE
Brendan Casey, CEO, swiftQueue
Conor OByrne, CEO, RelateCare
Prof Ita Richardson, Principal Investigator of ARCH
Prof Richardson has graduated 14 PhD students and 1 Habilitation student to completion, is currently supervising 4 PhD students, some of whom are part-time and industry-based and has supervised Senior Research Fellows and Research Fellows for the past 15 years. Prof Richardson has over 150 publications in refereed journals and conferences, has published 11 book chapters and edited 7 published books. Prof Richardson’s industry-based research has been with many indigenous Irish companies such as HomeSafe Care and Ocuco, and multi-national organisations (for example, IBM Dublin, Robert Bosch GmbH and Siemens Corporate Research). Her current collaborations include Vitalograph, Intel Shannon and the Health Service Executive, specifically within Limerick Public Hospitals, where her team have developed H-QAP – a Hospital Quality Assurance Program. Current projects include the establishment of an Innovation model for Connected Health development in Clinical situations, and an Investigation into measurable improvements within Radiography due to Connected Health implementation.
Prof Brian Caulfield, Principal Investigator
Prof Caulfield’s research programme is focussed on exploiting technological advances to enhance human performance in the fields of connected health and sport. He has a Bachelors degree in Physiotherapy, a Masters in Medical Science, and a PhD in Medicine from UCD. Prior to returning to complete his PhD studies he worked as a clinical Physiotherapist in the USA and in Ireland. Within UCD he has served as Director of Research and Innovation in the School of Physiotherapy & Performance Science and as Dean of Physiotherapy.
Brian has over 10 years of working at the interface of technology and human performance in health and sport, initially focussing on physical rehabilitation and recently on the application of connected health solutions to chronic disease management. He has worked closely with industry since the late 1990s, beginning as a R&D consultant to Medisolve Ltd and Biomedical Research Ltd, and progressing to collaborative applied research with a wide range of local and international companies in recent years. His research has led to significant commercial opportunities in terms of exploitation of intellectual property by industry partners and spin out activity. He has co-authored over 160 research publications and 6 patents.
Prof Susi Geiger, Principal Investigator of ARCH
As a Principal Investigator in ARCH, an Enterprise Ireland and IDA sponsored five-year research programme on connected health, Susi is leading the change work package on this programme. In the past, she has gained research funding from the prestigious Leverhulme Foundation, UK, been a Visiting Scholar at the University of Auckland, taught extensively in South East Asia and worked with a range of industrial and consumer companies in the pharmaceuticals, health care, specialist chemicals and other sectors. Since 2007 Susi has designed and delivered a wide range of marketing and sales modules on open and customized programmes for UCD Business School Executive Development, working for instance with companies such as Alltech, the Irish Stock Exchange, the Pharmaceutical Managers of Ireland, and others. Susi has served as the Vice-Principal for Research, Innovation and Impact at the UCD School of Business from 2011 until 2015; she has also directed the Diploma in Sales Management for UCD Smurfit Executive Development from 2011 to 2014..
Dr Gerardine Doyle Co-Principal Investigator, Change Team
Gerardine was an ARCH Principal Investigator and led the Healthcare Economics team within the initial research programme and is Co-Principal Investigator within the Change team. Gerardine was Principal investigator in the European Health Literacy Survey where she led the work package, ‘Valorisation activities for stakeholders at the national and regional levels’. This project was awarded the European Health Award by the European Health Forum Gastein on 3 October 2012. Gerardine has recently completed a study funded under the EU Seventh Framework Programme entitled ‘Enhancing the (cost-) effectiveness of diabetes self-management education: A comparative assessment of different educational approaches and conditions for successful implementation’ (DIABETES LITERACY) where she was Principal Investigator and led the Cost Analysis work package.
Gerardine was a Co-Investigator for a study Commissioned by the Clinical Effectiveness Unit Department of Health in 2015 to support the development of a National Clinical Guideline Communication (Clinical Handover) in Acute and Children’s Hospital Services: National Clinical Guideline No.11. Dublin: Department of Health where she led the Budget Impact Analysis.
Gerardine has acted as an expert evaluator for the European Commission, Directorate General for Research & Innovation for the FP7 programme, Health 2013 Innovation and Horizon 2020. Gerardine has served as a member of the audit committee of the Health Service Executive.